Symyx has appointed John Senaldi as senior vice president of Symyx and president of its High Productivity Research (HPR) business unit
Accelerated Technology Laboratories (ATL) has added Dax Morgan to its LIMS sales and implementation team
IDBS has expanded its Asia Pacific presence with new centres in China and Australia, providing direct local support and training, along with sales and business development for the entire portfolio of IDBS products
Chris Denly has been appointed as sales manager, maths and simulation at Adept Scientific
Radiochromatography specialist LabLogic Systems has appointed Bernard Sellier as sole distributor of its software and instrumentation in France
Platform Computing has appointed Jeffrey Galin as vice president of sales for Platform ISF, its private cloud management software, and Phil Morris as chief technology officer for its HPC business unit
Strand Life Sciences has appointed Thon de Boer, formerly of Agilent Technology, as its senior director of product management, software
George Shanks has been appointed CEO of Dezineforce, the provider of advanced design optimisation tools. Former CEO Dr Peter Collins moves to commercial director and will continue to serve on the board
OCF, the UK HPC integrator, has appointed former SGI and ClusterVision sales specialist Georgina Ellis as sales executive, with a primary focus on maintaining and growing OCF's presence in the academic research community
Symyx has expanded its European operation with several new appointments, including the promotion of Julie Page to head the European office
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
